在多发性骨髓瘤治疗中识别和向突变新抗原
Valentina Urzì Brancati1, Letteria Minutoli1, Herbert Ryan Marini1
1Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
Current oncology (Toronto, Ont.)
|May 26, 2023
概括
多发性骨髓瘤 (MM) 是一种具有挑战性的癌症. 本综述探讨了新抗原作为潜在的预后因素和治疗点,包括双特异性抗体和MM的CAR-T细胞疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 多发性骨髓瘤 (MM) 涉及骨髓中异常的血细胞增殖,导致显著的发病率.
- 免疫系统在MM中遇到新抗原,这些新抗原可以是公共的 (共享的) 或私有的 (患者特定的).
- 公开的新抗原是有前途的治疗点,因为它们的频繁发生和瘤作用.
研究的目的:
- 在多发性骨髓瘤患者中分析新抗原.
- 评估新抗原作为MM的预后因素.
- 评估新抗原作为MM的治疗点.
主要方法:
- 对MM中新抗原鉴定和表征的最新文献的综述.
- 对针对新抗原的治疗策略的分析.
- 对MM治疗的双特异性,三特异性和结合性抗体的评估.
- 对复发性/耐药性MM的仿制抗原受体T细胞 (CAR-T) 治疗的审查.
主要成果:
- 公共和私人的新抗原都存在于多发性骨髓瘤中.
- 针对免疫原性新抗原显示出对瘤控制的潜力.
- 针对MM,正在研究各种基于抗体的疗法和CAR-T细胞.
结论:
- 新抗原代表了在多发性骨髓瘤中预后评估和治疗干预的可行途径.
- 个性化和向性疗法,包括基于抗体和细胞疗法,有望改善MM的结果.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K